Sort   by:  
 Page size 
ProteomicsA new multiplexed plasma biomarker panel developed using targeted proteomics and machine learning has diagnostic and prognostic potential in children with hypertrophic cardiomyopathy
Background Hypertrophic cardiomyopathy (HCM) is defined clinically by pathological left ventricular hypertrophy (LVH). We have previously developed a plasma proteomics biomarker panel that correlates with clinical markers of disease severity and sudden cardiac death (SCD) risk in adult patients with...
ORGANISM(S): Homo sapiens (Human) 
2024-07-03 | PXD045304 | Pride
Childhood-onset hcm proteomics 
ProteomicsMouse model for hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes that code for the structural proteins of the sarcomere, is the most common inherited heart disease. HCM is associated with progressive myocardial hypertrophy and fibrosis, ventricular dysfunction, and arrhythmias. Dise...
ORGANISM(S): Mus musculus (Mouse) 
2025-01-20 | PXD038911 | Pride
Mouse Proteomics Heart Hypertrophic cardiomyopathy Dda 
ProteomicsTargeting inflammation and metabolism in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes that code for the structural proteins of the sarcomere, is the most common inherited heart disease. HCM is associated with progressive myocardial hypertrophy and fibrosis, ventricular dysfunction, and arrhythmias. Dise...
ORGANISM(S): Mus musculus (Mouse) 
2026-06-29 | PXD067090 | Pride
Pioglitazone Hypertrophic cardiomyopathy Myocardial hypertrophy 
ProteomicsTargeting inflammation and metabolism in hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes that code for the structural proteins of the sarcomere, is the most common inherited heart disease. HCM is associated with progressive myocardial hypertrophy and fibrosis, ventricular dysfunction, and arrhythmias. Dise...
ORGANISM(S): Mus musculus (Mouse) 
2026-06-29 | PXD067096 | Pride
Pioglitazone Hypertrophic cardiomyopathy Myocardial hypertrophy 
UnknownNovel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.
Not available
S-EPMC11188636 | biostudies-literature
Sort   by:  
 Page size